Form 4: OrbiMed Advisors Sells NeuroPace Inc (NPCE) Shares in Multiple Transactions

OrbiMed Advisors LLC, a significant shareholder of NeuroPace Inc, has sold a portion of its holdings in a series of transactions between May 1st and May 3rd, 2024.

Summary

• OrbiMed Advisors LLC, along with OrbiMed Capital GP VI LLC, filed a Form 4 detailing changes in beneficial ownership of NeuroPace Inc (NPCE) stock.
• The transactions involved the sale of common stock on May 1st, 2nd, and 3rd of 2024.
• On May 1st, 15,690 shares were sold at a price of $14.02.
• On May 2nd, 8,842 shares were sold at a price of $14.01.
• On May 3rd, 4,674 shares were sold at a price of $14.03.
• Following these transactions, OrbiMed Advisors indirectly holds 3,406,335 shares of NeuroPace Inc.
• The shares are held of record by OrbiMed Private Investments VI, LP (OPI VI), with OrbiMed Capital GP VI LLC (GP VI) as the general partner and OrbiMed Advisors LLC as the managing member of GP VI.
• OrbiMed Advisors disclaims beneficial ownership of the securities except to the extent of its pecuniary interest.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports transactions. The fact that a large shareholder is selling shares could be seen as slightly negative, but without more context, it's difficult to assess the overall impact.

Negatives

• OrbiMed Advisors, a major shareholder, reduced its stake in NeuroPace Inc.

Risks

• Continued selling pressure from major shareholders like OrbiMed could negatively impact NeuroPace Inc.'s stock price.

Management Comments

• Carl L. Gordon, Member of OrbiMed Advisors LLC and OrbiMed Capital GP VI LLC, disclaims beneficial ownership of the shares except to the extent of its pecuniary interest.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by significant shareholders, providing transparency to the market.

Stakeholder Impact

• The sale of shares by a major shareholder could potentially impact the confidence of other shareholders.
• The transactions may influence the short-term stock price of NeuroPace Inc.

Key Dates